166 related articles for article (PubMed ID: 15580649)
1. In vivo administration of the C16:0 fatty acid isoform of sulfatide increases pancreatic sulfatide and enhances glucose-stimulated insulin secretion in Zucker fatty (fa/fa) rats.
Blomqvist M; Carrier M; Andrews T; Pettersson K; Månsson JE; Rynmark BM; Fredman P; Buschard K
Diabetes Metab Res Rev; 2005; 21(2):158-66. PubMed ID: 15580649
[TBL] [Abstract][Full Text] [Related]
2. Selective lack of the C16:0 fatty acid isoform of sulfatide in pancreas of type II diabetic animal models.
Blomqvist M; Osterbye T; Månsson JE; Horn T; Buschard K; Fredman P
APMIS; 2003 Sep; 111(9):867-77. PubMed ID: 14510644
[TBL] [Abstract][Full Text] [Related]
3. C16:0 sulfatide inhibits insulin secretion in rat beta-cells by reducing the sensitivity of KATP channels to ATP inhibition.
Buschard K; Blomqvist M; Månsson JE; Fredman P; Juhl K; Gromada J
Diabetes; 2006 Oct; 55(10):2826-34. PubMed ID: 17003349
[TBL] [Abstract][Full Text] [Related]
4. Insulin secretory defect in Zucker fa/fa rats is improved by ameliorating insulin resistance.
de Souza CJ; Yu JH; Robinson DD; Ulrich RG; Meglasson MD
Diabetes; 1995 Aug; 44(8):984-91. PubMed ID: 7622005
[TBL] [Abstract][Full Text] [Related]
5. Glucose refractoriness of beta-cells from fed fa/fa rats is ameliorated by nonesterified fatty acids.
Chan CB; Surette JJ
Can J Physiol Pharmacol; 1999 Dec; 77(12):934-42. PubMed ID: 10606439
[TBL] [Abstract][Full Text] [Related]
6. Sulfatide controls insulin secretion by modulation of ATP-sensitive K(+)-channel activity and Ca(2+)-dependent exocytosis in rat pancreatic beta-cells.
Buschard K; Høy M; Bokvist K; Olsen HL; Madsbad S; Fredman P; Gromada J
Diabetes; 2002 Aug; 51(8):2514-21. PubMed ID: 12145165
[TBL] [Abstract][Full Text] [Related]
7. Sulfatide is associated with insulin granules and located to microdomains of a cultured beta cell line.
Blomqvist M; Osterbye T; Månsson JE; Horn T; Buschard K; Fredman P
Glycoconj J; 2002 Jul; 19(6):403-13. PubMed ID: 14707487
[TBL] [Abstract][Full Text] [Related]
8. Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling.
Nolan CJ; Leahy JL; Delghingaro-Augusto V; Moibi J; Soni K; Peyot ML; Fortier M; Guay C; Lamontagne J; Barbeau A; Przybytkowski E; Joly E; Masiello P; Wang S; Mitchell GA; Prentki M
Diabetologia; 2006 Sep; 49(9):2120-30. PubMed ID: 16868750
[TBL] [Abstract][Full Text] [Related]
9. Modulation by glucose of insulin secretion and glucose phosphorylating activity in cultured pancreatic islets from obese (fa/fa) Zucker rats.
Chan CB; Lowe JM; Debertin WJ
Int J Obes Relat Metab Disord; 1996 Feb; 20(2):175-84. PubMed ID: 8646255
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide (P32/98) in fatty Zucker rats with incipient and manifest impaired glucose tolerance.
Augstein P; Berg S; Heinke P; Altmann S; Salzsieder E; Demuth HU; Freyse EJ
Diabetes Obes Metab; 2008 Sep; 10(10):850-61. PubMed ID: 17970756
[TBL] [Abstract][Full Text] [Related]
11. The glycosphingolipid sulfatide in the islets of Langerhans in rat pancreas is processed through recycling: possible involvement in insulin trafficking.
Fredman P; Mânsson JE; Rynmark BM; Josefsen K; Ekblond A; Halldner L; Osterbye T; Horn T; Buschard K
Glycobiology; 2000 Jan; 10(1):39-50. PubMed ID: 10570222
[TBL] [Abstract][Full Text] [Related]
12. Uptake of the glycosphingolipid sulfatide in the gastrointestinal tract and pancreas in vivo and in isolated islets of Langerhans.
Blomqvist M; Osterbye T; Månsson JE; Buschard K; Fredman P
Lipids Health Dis; 2006 Oct; 5():26. PubMed ID: 17044925
[TBL] [Abstract][Full Text] [Related]
13. The effects of high-fat diet on exercise-induced changes in metabolic parameters in Zucker fa/fa rats.
Kibenge MT; Chan CB
Metabolism; 2002 Jun; 51(6):708-15. PubMed ID: 12037723
[TBL] [Abstract][Full Text] [Related]
14. Augmented insulinotropic action of arachidonic acid through the lipoxygenase pathway in the obese Zucker rat.
Ahrén B; Magrum LJ; Havel PJ; Greene SF; Phinney SD; Johnson PR; Stern JS
Obes Res; 2000 Sep; 8(6):475-80. PubMed ID: 11011915
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the enteroinsular axis in two strains of obese rat, the fatty Zucker and the JCR:LA-corpulent.
Pederson RA; Campos RV; Buchan AM; Chisholm CB; Russell JC; Brown JC
Int J Obes; 1991 Jul; 15(7):461-70. PubMed ID: 1894423
[TBL] [Abstract][Full Text] [Related]
16. Limited role for SREBP-1c in defective glucose-induced insulin secretion from Zucker diabetic fatty rat islets: a functional and gene profiling analysis.
Parton LE; McMillen PJ; Shen Y; Docherty E; Sharpe E; Diraison F; Briscoe CP; Rutter GA
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E982-94. PubMed ID: 16772326
[TBL] [Abstract][Full Text] [Related]
17. GPR40 protein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity-prone and non-obese type 2 diabetes in rats.
Meidute Abaraviciene S; Muhammed SJ; Amisten S; Lundquist I; Salehi A
Mol Cell Endocrinol; 2013 Dec; 381(1-2):150-9. PubMed ID: 23911664
[TBL] [Abstract][Full Text] [Related]
18. A low protein diet lowers islet insulin secretion but does not alter hyperinsulinemia in obese Zucker (fa/fa) rats.
Tse EO; Gregoire FM; Magrum LJ; Johnson PR; Stern JS
J Nutr; 1995 Jul; 125(7):1923-9. PubMed ID: 7616309
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Prediabetic State in a Novel Rat Model of Type 2 Diabetes, the ZFDM Rat.
Gheni G; Yokoi N; Beppu M; Yamaguchi T; Hidaka S; Kawabata A; Hoshino Y; Hoshino M; Seino S
J Diabetes Res; 2015; 2015():261418. PubMed ID: 25961052
[TBL] [Abstract][Full Text] [Related]
20. Enhanced insulin secretion and calcium uptake by Zucker "fatty" rat islets.
Pansini AR; Tolman EL
Horm Metab Res; 1981 Aug; 13(8):430-3. PubMed ID: 7035321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
